Keith McCrae, MD, Oncology, Cleveland, OH, Cleveland Clinic

KeithRMcCraeMD

Oncology Cleveland, OH

Hematologic Oncology

Director, Benign Hematology, Professor of Molecular Medicine, Cleveland Clinic

Dr. McCrae is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. McCrae's full profile

Already have an account?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology, 1985 - 1988
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1982 - 1985
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1982
  • Dartmouth CollegeBA, Summa Cum Laude, 1978

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1999 - 2022
  • PA State Medical License
    PA State Medical License 1985 - 2002
  • NC State Medical License
    NC State Medical License 1982 - 1985
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Teacher of the Year Taussig Cancer Institute, Cleveland Clinic, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
  • American�s Top Doctors Castle Connoly, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Kininogen deficiency or depletion reduces enhanced pause independent of pulmonary inflammation in a house dust mite-induced murine asthma model  
    Yang J, van 't Veer C, Roelofs JJTH, van Heijst JWJ, de Vos AF, McCrae KR, Revenko AS, Crosby J, van der Poll T., Am J Physiol Lung Cell Mol Physiol., 1/1/2019
  • The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation  
    Khorana AA, McCrae K, Milentijevic D, McCormick N, Lalibert� F, Crivera C, Lefebvre P, Lejeune D, Rozjabek H, Schein J, Streiff MB., Am J Hematol., 1/1/2019
  • Plasma Kallikrein Structure Reveals Apple Domain Disc Rotated Conformation Compared to Factor XI  
    Li C, Voos KM, Pathak M, Hall G, McCrae KR, Dreveny I, Li R, Emsley J., J. Thromb Haemost, 1/1/2019
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Characterization of Recombinant _2GPI Using Hydrogen-Deuterium Exchange and X-Ray Crystallography
    Keith R McCrae, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Identifying miRNA Biomarkers and Predicted Targets Associated with Venous Thromboembolism in Colorectal Cancer Patients
    Keith R McCrae, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations
    Keith R McCrae, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Extracellular vesicles in cancer-associated thrombosis 
    Evans Center, Boston University School of Medicine, Boston MA - 1/1/2019
  • Pomalidomide in Hereditary Hemorrhagic Telangiectasia 
    San Juan, PRI - 1/1/2019
  • Special Symposium on the Basic Science of Hemostasis and Thrombosis 
    60th American Society of Hematology Annual Meeting - 12/3/2018
  • Join now to see all

Press Mentions

  • No Need for Bone Marrow Exam in ITP Diagnosis
    No Need for Bone Marrow Exam in ITP DiagnosisJanuary 21st, 2020
  • Clinical Challenges: ITP in Pregnancy
    Clinical Challenges: ITP in PregnancyDecember 4th, 2018
  • Clinical Trials Show Direct Oral Anticoagulants Are Safe, Effective for Cancer-Related Venous Thromboembolism
    Clinical Trials Show Direct Oral Anticoagulants Are Safe, Effective for Cancer-Related Venous ThromboembolismSeptember 18th, 2018
  • Join now to see all

Grant Support

  • Regulation Of Angiogenesis By KininogenNational Heart, Lung, And Blood Institute2010–2012
  • Regulation Of Angiogenesis By KininogenNational Heart, Lung, And Blood Institute2009–2010
  • Role Of Microparticles In The Anti-Phospholipid SyndromeNational Heart, Lung, And Blood Institute2006–2010
  • Hematology Training GrantNational Heart, Lung, And Blood Institute2004–2010
  • Transfusion Medicine/Hemostasis Clinical Research NetworkNational Heart, Lung, And Blood Institute2009
  • Tropomyosin In The Antiangiogenic Activity Of HKANational Heart, Lung, And Blood Institute2004–2007
  • Transfusion Medicine/Hemostasis Clinical Research Netwo*National Heart, Lung, And Blood Institute2002–2006
  • Anti Angiogenic Activity Of Cleaved HMW KininogenNational Cancer Institute2000–2004
  • Urokinase Receptor And Trophoblast InvasionNational Heart, Lung, And Blood Institute1997
  • Urokinase Receptor And Trophoblast InvasionNational Heart, Lung, And Blood Institute1994–1997
  • Role Of The Urokinase Receptor In Trophoblast InvasionNational Heart, Lung, And Blood Institute1993
  • Immune Trophoblast InjuryEunice Kennedy Shriver National Institute Of Child Health &Human Development1990–1992
  • Lupus Anticoagulant Induced Endothelial InjuryNational Heart, Lung, And Blood Institute1987–1988

Other Languages

  • Spanish

Hospital Affiliations